ORLANDO (EGMN) - Among patients with cancer-associated thrombosis, women and those with lung cancer or a history of at least one venous thromboembolic event are at significantly increased risk for recurrent emboli and may require prophylaxis with low-molecular-weight heparin or more aggressive anticoagulation, investigators have reported.In contrast, patients with stage I malignancies or breast cancer are at relatively low risk for venous thromboembolism (VTE) recurrence and may need...